Bayomi M A, al-Suwayeh S A, el-Helw A M, Mesnad A F
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Pharm Acta Helv. 1998 Dec;73(4):187-92. doi: 10.1016/s0031-6865(98)00020-x.
Sustained release casein-chitosan microspheres containing diltiazem hydrochloride (DTZ) were prepared with colloidal coacervation technique in a completely aqueous environment. The interaction between chitosan solution in dilute acetic acid (5% v/v) and casein solution in 0.5 M sodium hydroxide was the basis for the microspheres formation. Formaldehyde was used for the surface hardening of the droplets by cross-linking and thus fixing the shape and surface morphology of the formed microspheres. The entrapment efficiencies of the microspheres were variables (14.5-53.7%) depending on the preparation conditions. The prepared microspheres exhibited an angle of repose values between 31.9-42.0 degrees indicating good free flowing nature, whereas DTZ powder as such was non-flowable. The dissolution profiles of DTZ from casein-chitosan microspheres showed retarded release pattern of the drug into distilled water. Casein and chitosan concentrations, initial drug concentration and stirring time were found to be the main parameters that affect the properties and the performance of the prepared microspheres. The retarded release of DTZ was increased by increasing casein concentration, and stirring time. On the other hand, increasing chitosan concentration and using high initial drug loading showed a fast drug release.
采用凝聚法在完全水相环境中制备了含盐酸地尔硫䓬(DTZ)的缓释酪蛋白-壳聚糖微球。稀醋酸(5% v/v)中的壳聚糖溶液与0.5 M氢氧化钠中的酪蛋白溶液之间的相互作用是微球形成的基础。甲醛用于通过交联使液滴表面硬化,从而固定所形成微球的形状和表面形态。微球的包封率因制备条件而异(14.5 - 53.7%)。所制备的微球休止角在31.9 - 42.0度之间,表明具有良好的自由流动性质,而DTZ粉末本身则不具有流动性。DTZ从酪蛋白-壳聚糖微球中的溶出曲线显示药物向蒸馏水中的释放模式延迟。发现酪蛋白和壳聚糖浓度、初始药物浓度和搅拌时间是影响所制备微球性质和性能的主要参数。增加酪蛋白浓度和搅拌时间可使DTZ的延迟释放增加。另一方面,增加壳聚糖浓度和使用高初始药物载量则显示药物快速释放。